Exact Sciences
EXAS
#1727
Rank
NZ$16.78 B
Marketcap
$90.72
Share price
-0.30%
Change (1 day)
-15.68%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Operating Margin for Exact Sciences (EXAS)

Operating Margin as of November 2024 (TTM): -8.07%

According to Exact Sciences's latest financial reports and stock price the company's current Operating Margin is -8.07%. At the end of 2023 the company had an Operating Margin of -8.07%.

Operating Margin history for Exact Sciences from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-8.07%-73.41%
2022-30.35%-36.34%
2021-47.68%-14.23%
2020-55.59%19.85%
2019-46.38%20.41%
2018-38.52%-10.58%
2017-43.08%-74.4%
2016-168.26%-57.95%
2015-400.14%-92.8%
2014-5,561.07%395.97%
2013-1,121.26%-11.36%
2012-1,264.99%83.89%
2011-687.92%218.95%
2010-215.68%10.94%
2009-194.41%-82.01%
2008-1,080.85%171.83%
2007-397.61%39.94%
2006-284.13%-19.54%
2005-353.13%-9.21%
2004-388.96%-60.87%
2003-994.07%-70.16%
2002-3,331.44%-92.77%
2001-46,049.02%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-20.72% 156.75%๐Ÿ‡บ๐Ÿ‡ธ USA
31.38%-488.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-13.71% 69.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-124.57% 1,443.62%๐Ÿ‡บ๐Ÿ‡ธ USA
15.40%-290.83%๐Ÿ‡ซ๐Ÿ‡ท France

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.